Kidney stone pain is the kind that tends to be described in superlatives by anyone who has experienced it. But beyond the acute suffering, stones carry a less widely known risk: repeated episodes are linked to long-term kidney damage, urinary obstruction and in serious untreated cases, a dangerous bloodstream infection. Roughly one in ten Americans develops kidney stones at some point, and that rate has been climbing steadily for decades.
Recurrence is common, which makes prevention not just useful but essential for people who are prone to them. A recent large-scale review published in the journal Annals of Internal Medicine analyzed a broad body of existing research and identified a combination of interventions that meaningfully reduce how often stones return. The findings reinforce some familiar guidance while bringing welcome clarity to a few areas where conventional wisdom has been misleading.
The basic mechanism worth understanding
Kidney stones form when minerals in urine, primarily calcium, oxalate or phosphate, reach a concentration high enough to crystallize. The most common types are calcium oxalate and calcium phosphate stones. When there is not enough fluid to dilute those minerals or enough of the right compounds to prevent crystal formation, the conditions for a stone are in place. Each intervention identified in the review targets a different point in that process.
Hydration as the most accessible tool
The simplest and most universally applicable prevention strategy is also the one that requires no prescription. Diluting urine sufficiently keeps mineral concentrations below the threshold at which crystals form. The practical target is producing roughly two and a half liters of urine daily, which typically requires drinking around 100 fluid ounces of fluid throughout the day. For most people that means being more deliberate about consistent intake rather than waiting until thirst sets in.
What diet changes actually help
The dietary picture is more nuanced than most people realize, and one piece of it is genuinely counterintuitive.
High sodium intake causes the kidneys to excrete more calcium into urine, raising the concentration of the mineral most involved in stone formation. Reducing sodium is therefore one of the more direct dietary levers available. High consumption of animal protein presents a related problem by raising uric acid levels and reducing citrate, a compound that naturally inhibits stone formation in urine.
The counterintuitive piece involves calcium itself. Many people who have had calcium-based kidney stones assume they should reduce their calcium intake, but the evidence consistently shows that doing so makes things worse. When dietary calcium is too low, the gut cannot adequately bind oxalate during digestion, which means more oxalate reaches the kidneys where it contributes directly to stone formation. Most adults benefit from maintaining a daily calcium intake between 1,000 and 1,200 milligrams, ideally consumed with meals rather than as isolated supplements. The goal is not to restrict calcium but to keep sodium and animal protein in check while keeping calcium intake at a healthy and consistent level.
Alkali therapy and what the data showed
For people with recurring stones, oral alkali therapy offers a significant reduction in recurrence. The most common form is potassium citrate, taken as a tablet, which raises the pH of urine and directly increases citrate levels, restoring a chemical environment less hospitable to stone formation. Across four trials reviewed by researchers, this treatment was associated with 333 fewer stone recurrences per 1,000 patients, a substantial effect.
Lemon juice was also studied as a more accessible alternative given its natural citrate content. It showed a more modest benefit and was associated with a small increase in side effects, making it a secondary option rather than a straightforward substitute.
Medications with meaningful track records
Two prescription medications also showed clear benefits in the review. Thiazide diuretics, which increase urination, work by prompting the kidneys to reabsorb calcium rather than release it into urine, effectively reducing the raw material available for stone formation. Across three trials, this approach was associated with roughly 217 fewer recurrences per 1,000 patients.
Allopurinol, a medication that lowers uric acid production, showed 265 fewer recurrences per 1,000 patients across two trials without a meaningful increase in adverse events, making it a well-tolerated option for people whose stones are linked to elevated uric acid levels.
What the review makes clear
The findings from this review do not introduce entirely new ideas, but they strengthen the evidence behind existing recommendations and clarify which interventions carry the most weight. Notably, the strategies with the clearest and most accessible impact require no prescription at all. Drinking more water, reducing sodium and limiting animal protein are steps anyone can take with immediate effect.
For people with a personal or family history of kidney stones, that combination of accessible habits alongside appropriately prescribed medication where warranted represents the most evidence-supported path currently available toward breaking the cycle of recurrence. As with any change to a health routine, the guidance of a physician familiar with an individual’s specific stone type and history remains essential.
